Загрузка...

Directed Evolution of AAV Serotype 5 for Increased Hepatocyte Transduction and Retained Low Humoral Seroreactivity

Most recombinant adeno-associated virus (AAV) capsids utilized in liver gene therapy have significant levels of pre-existing neutralizing antibodies in the human population. These neutralizing factors limit the patient pools eligible for receiving AAV-mediated therapies. AAV serotype 5 (AAV5) does n...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Ther Methods Clin Dev
Главные авторы: Qian, Randolph, Xiao, Bin, Li, Juan, Xiao, Xiao
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Gene & Cell Therapy 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7773954/
https://ncbi.nlm.nih.gov/pubmed/33426144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.10.010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!